Exciting Advances in GERD Treatment with RefluxStop
Implantica AG, a leader in medical technology, recently unveiled some promising results from an independent study on the RefluxStop implantable device, designed for treating gastroesophageal reflux disease (GERD). This groundbreaking device has demonstrated significant results, with over 90% of GERD patients reporting improved quality of life after a follow-up of two years. These findings were highlighted at a recent conference, capturing the attention of many in the medical field.
Key Findings from the Study
The study monitored 158 patients and revealed impressive effectiveness and safety results. After two years, an astonishing 96.4% of those involved were able to stop taking their regular PPI medication, a common treatment for GERD. Additionally, a 90.9% improvement in the GERD health-related quality of life (GERD-HRQL) score was recorded. Many participants faced complex health challenges: 22% had sizable hiatal hernias larger than 3 cm, while 44% dealt with active esophagitis.
Insights from Leading Surgeons
The research was contributed to by prominent anti-reflux surgeons in Germany, including Dr. Moustafa Elshafei and Dr. Thorsten Lehmann. Their input has been critical to this study. Dr. Elshafei expressed his excitement about the findings, highlighting the strong interest surrounding the RefluxStop device among his peers in the UK.
Perspectives from Dr. Lehmann
Dr. Lehmann discussed how the RefluxStop device could offer surgical options for patients with large hiatal hernias, potentially enhancing their treatment pathways. He has observed excellent results in nearly 200 patients he has treated using RefluxStop in the last three years.
Implantica's Vision and Commitment
Dr. Peter Forsell, the founder and CEO of Implantica, expressed his gratitude to the surgeons for their efforts in sharing the study’s results. He noted the importance of GERD as it impacts around 9.5 million people in the UK. The company is optimistic about making the RefluxStop treatment more accessible, especially in NHS centers that are likely to adopt this technology soon.
About the RefluxStop Device
This innovative device is set to transform how GERD is treated. Unlike conventional surgical methods that may cause side effects such as difficulty swallowing or reduced ability to belch, RefluxStop targets the root cause of acid reflux without applying unnecessary pressure on the food passage. Rather, it helps restore the natural positioning of the lower esophageal sphincter, making the body better equipped to manage acid reflux.
About Implantica
Implantica AG is focused on progressing medical technology. Their flagship product, RefluxStop™, marks a significant advancement in the realm of anti-reflux treatments, bolstered by substantial clinical trial data. The company is also working on an eHealth platform that aims to monitor health parameters remotely, further enhancing the landscape of medical treatment through innovation.
Frequently Asked Questions
What is the RefluxStop device?
The RefluxStop device is an implantable solution aimed at effectively managing gastroesophageal reflux disease (GERD). It seeks to provide long-lasting relief without the complications often associated with traditional surgical options.
What were the outcomes of the recent study regarding the RefluxStop device?
The study indicated that patients experienced over a 90% improvement in their GERD-related quality of life within two years, with most participants able to stop using standard PPI medications.
Who were the key figures involved in the study?
Prominent German anti-reflux surgeons, especially Dr. Moustafa Elshafei and Dr. Thorsten Lehmann, played essential roles in conducting and sharing the findings of the study.
How committed is Implantica to patient care?
Implantica is dedicated to rapidly expanding access to RefluxStop treatment in healthcare facilities, particularly within the NHS, to help the significant number of individuals affected by GERD.
In what way does RefluxStop stand apart from traditional GERD surgeries?
RefluxStop functions without applying continuous pressure to the esophagus, working instead to restore the natural position of the sphincter, contrasting with traditional methods that often lead to side effects like difficulty swallowing.
